Raiffeisen Bank International AG
BankPosition in ESPR — Esperion Therapeutics, Inc.
CIK 2044885
VIENNA, C4
Position in ESPR
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$0
+$0 QoQ
Shares Held
0
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
7 quarters on record
Common Shares in ESPR Over Time
Shares Held
Position Value (USD)
Derivatives in ESPR
reported options exposure · as of Jun 30, 2026CallValue
$0
CallShares
4,400
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Raiffeisen Bank International AG holds $7,748,668 across 4 Drug Manufacturers - Specialty & Generic names.
All Filings in ESPR
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | — | 4,400 | Call | Sole | 2026-08-03 | |
| 2026-03-31 | — | 4,400 | Call | Sole | 2026-04-24 | |
| 2025-12-31 | — | 4,400 | Call | Sole | 2026-02-12 | |
| 2025-09-30 | — | 4,400 | Call | Sole | 2025-11-10 | |
| 2025-06-30 | — | 4,400 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | — | 4,400 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | — | 4,400 | Shares | Defined | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||